Phase 3, Double-Blind, Placebo-Controlled, Study to Evaluate the Analgesic Efficacy, Safety, and Tolerability of Buprenorphine HCl Buccal Film in Opioid-Naive Subjects With Chronic Lower Back Pain Requiring Opioid Analgesia
Phase of Trial: Phase III
Latest Information Update: 02 Mar 2017
At a glance
- Drugs Buprenorphine (Primary)
- Indications Back pain
- Focus Registrational; Therapeutic Use
- Sponsors BioDelivery Sciences International; Endo Pharmaceuticals
- 26 Oct 2015 Results presented in Endo Pharmaceuticals media release.
- 26 Oct 2015 According to Endo Pharmaceuticals media release, the US FDA has approved BELBUCATM (buprenorphine) buccal film for use in patients with chronic pain.
- 14 May 2015 Results published in an Endo Pharmaceuticals media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History